Vandetanib to Treat Children and Adolescents With Medullary Thyroid Cancer

NCT00514046 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

17

Enrollment

NIH

Sponsor class

Conditions

Medullary Thyroid Carcinoma
Multiple Endocrine Neoplasia Type 2A
Multiple Endocrine Neoplasia Type 2B

Interventions

DRUG: Vandetanib

Sponsor

National Cancer Institute (NCI)